31Jul
Department of Justice fines pharmaceutical company
Compliance Today (August 2020) - On May 7, the Department of Justice’s Antitrust Division announced a deferred prosecution agreement, in which Apotex Corp. agreed to pay a $24.1 million criminal penalty for price-fixing. The Florida-based company conspired with competitors to increase and maintain the price of pravastatin, a commonly prescribed cholesterol medication that lowers the risk of heart disease and stroke....
By:
Health Care Compliance Association (HCCA)
Related
While vacations and barbecues were the order of business for many this summer, New York’s lawmakers...
Read More >
This quarter’s issue includes summaries and associated court opinions of selected cases principally...
Read More >
The Federal Trade Commission, with the support of the Antitrust Division of the U.S. Department of J...
Read More >
Five In-Home Supportive Service (“IHSS”) providers filed a class-action lawsuit last month challen...
Read More >
For the first time in 40 years, the U.S. Department of Education (DOE) will make significant regulat...
Read More >
Effective December 20, 2019, the "Taxpayer Certainty and Disaster Tax Relief Act of 2019" makes two ...
Read More >